Literature DB >> 2452398

Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

M P Kamps1, B M Sefton.   

Abstract

Antibodies to phosphotyrosine were used to identify proteins phosphorylated on tyrosine in chicken embryo fibroblasts transformed by the oncogenes, v-src, v-yes, v-fps, v-ros, or v-erb-B. These antibodies allowed detection of a minimum of 50, 44, and 47 bands in immunoblots of cellular lysates from fibroblasts transformed by v-src, v-yes, or v-fps respectively. Eight of these bands were also detected in fibroblasts transformed by v-ros and v-erb-B, suggesting that the cellular transformation induced by v-ros, v-erb-B, v-src, v-yes, and v-fps may be achieved by the phosphorylation of some of the same proteins. The viruses SD10 and SD11 are point mutants of the Prague-C strain of Rous sarcoma virus that encode non-myristylated p60v-src. They do not induce the transformation of chicken fibroblasts. Approximately thirty bands were detected by antibodies to phosphotyrosine in fibroblasts transformed by wild-type Prague-RSV-C, only four of which were not substrates nonmyristylated mutant p60v-src. This suggests that the phosphorylation of a large subset of the substrates of p60v-src is not sufficient for transformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452398

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  134 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

4.  Inhibition of v-src-induced transformation by a GTPase-activating protein.

Authors:  M Nori; U S Vogel; J B Gibbs; M J Weber
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.

Authors:  S B Kanner; A B Reynolds; R R Vines; J T Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Purification and Characterization of a Potato Tuber Acid Phosphatase Having Significant Phosphotyrosine Phosphatase Activity.

Authors:  K. S. Gellatly; GBG. Moorhead; SMG. Duff; D. D. Lefebvre; W. C. Plaxton
Journal:  Plant Physiol       Date:  1994-09       Impact factor: 8.340

7.  Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.

Authors:  C L Burke; D F Stern
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Authors:  F Giorgino; A Almahfouz; L J Goodyear; R J Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Profound differences in potassium current properties of normal and Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  H Repp; H Draheim; J Ruland; G Seidel; J Beise; P Presek; F Dreyer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.

Authors:  A G Batzer; P Blaikie; K Nelson; J Schlessinger; B Margolis
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.